Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders

Tetrabenazine for the Treatment of Tardive Dyskinesia

(2011) Jonathan G Leung et al.   ANNALS OF PHARMACOTHERAPY

Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors

(2011) Zhangyu Yao et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Tourette syndrome: Evolving concepts

(2011) Joseph Jankovic et al.   MOVEMENT DISORDERS

Management of Huntington’s disease: role of tetrabenazine

(2011) de Tommaso   Therapeutics and Clinical Risk Management

Role of Tetrabenazine for Huntington's Disease-Associated Chorea

(2010) L. H. Poon et al.   ANNALS OF PHARMACOTHERAPY

Huntington's disease: From molecular basis to therapeutic advances

(2010) Sylvia Krobitsch et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Huntington's disease: from molecular pathogenesis to clinical treatment

(2010) Christopher A Ross et al.   LANCET NEUROLOGY

Tetrabenazine is neuroprotective in Huntington's disease mice

(2010) Hongyu Wang et al.   Molecular Neurodegeneration

Tardive dyskinesia and other movement disorders secondary to aripiprazole

(2010) Maria Sierra Peña et al.   MOVEMENT DISORDERS

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators

(2009) Samuel Frank   BMC Neurology

Tetrabenazine

(2009) Alfonso Fasano et al.   EXPERT OPINION ON PHARMACOTHERAPY

A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles

(2009) Etienne A. Cartier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The molecular chaperone Hsc70 interacts with the vesicular monoamine transporter-2

(2009) Daniela F. Requena et al.   JOURNAL OF NEUROCHEMISTRY

Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3

(2009) L. A. Egana et al.   JOURNAL OF NEUROSCIENCE

Treatment of hyperkinetic movement disorders

(2009) Joseph Jankovic   LANCET NEUROLOGY

Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons

(2009) Thomas S. Guillot et al.   MOLECULAR NEUROBIOLOGY

Tourette??s Syndrome and Role??of??Tetrabenazine

(2008) Mauro Porta et al.   CLINICAL DRUG INVESTIGATION

A Study of Chorea After Tetrabenazine Withdrawal in Patients With Huntington Disease

(2008) Samuel Frank et al.   CLINICAL NEUROPHARMACOLOGY

Deletion of Go2α abolishes cocaine-induced behavioral sensitization by disturbing the striatal dopamine system

(2008) Irene Brunk et al.   FASEB JOURNAL

Ca2+-dependent Activator Proteins of Secretion Promote Vesicular Monoamine Uptake

(2008) Irene Brunk et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Comparison of Weight Gain in Treatments for Tourette Syndrome: Tetrabenazine Versus Neuroleptic Drugs

(2008) William G. Ondo et al.   JOURNAL OF CHILD NEUROLOGY

Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia

(2008) Christopher Kenney et al.   JOURNAL OF CLINICAL PHARMACOLOGY